Literature DB >> 15736550

Comparison of an immunochromatographic card test with night blood smear examination for detection of Wuchereria bancrofti microfilaria carriers.

S P Pani1, S L Hoti, P Vanamail, L K Das.   

Abstract

BACKGROUND: At present, two diagnostic tests--Og4C3 ELISA and an immunochromatographic card test (ICT)--are available to detect circulating filarial antigens of Wuchereria bancrofti in serum/whole blood samples collected during the day. We aimed to assess the sensitivity of the new format card test 'NOW ICT Filariasis' in detecting microfilaria carriers of W. bancrofti in comparison with conventional microscopic techniques and Og4C3 ELISA.
METHODS: A total of 200 persons were selected from two villages following a quota sampling design (100 in each village). The required number of houses was selected using a systematic sampling procedure with a random start of the first household. Blood samples were taken from all the available persons in each selected house until the quota of 100 was reached. The new format ICT test, Og4C3 ELISA and night blood smear examination for microfilaria were carried out following standard procedures.
RESULTS: The sensitivity of the new format ICT test was 100% among microfilaria carriers (detected by both early and late readings). The kappa statistic measure of agreement between the two readings of all the samples (n =200) tested was 0.811 (p<0.05). The new format test also reported 25% of microfilaria-negative individuals as being positive for circulating filarial antigens. However, the diagnostic lines were not stable beyond 10 minutes (particularly in the case of amicrofilaraemic persons). Though there was an overall agreement between the results of ICT and Og4C3 tests (kappa =0.612; p< 0.05), the sensitivity of the Og4C3 test was lower than that of ICT.
CONCLUSION: The new format ICT test is highly sensitive in detecting microfilaria carriers in endemic communities. Improvement in the format to provide stable diagnostic lines, specificity of the format and cost of the test kit are to be considered before its large-scale use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15736550

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  5 in total

1.  Cost-effective antigen testing for delimitation, monitoring and evaluation in bancroftian filariasis.

Authors:  L K Das; S P Pani; P Vanamail; G Vijayalakshmi; L J Debritto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-31       Impact factor: 3.267

2.  Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections.

Authors:  Rajeev K Mehlotra; Laurie R Gray; Melinda J Blood-Zikursh; Zachary Kloos; Cara N Henry-Halldin; Daniel J Tisch; Edward Thomsen; Lisa Reimer; Will Kastens; Manasseh Baea; Kaye Baea; Moses Baisor; Nandao Tarongka; James W Kazura; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

3.  Production, purification and diagnostic application of filarial recombinant protein WbSXP-1 expressed in salt inducible Escherichia coli.

Authors:  S Janardhan; P Pandiaraja; S Thirugnanam; M N Balamurali; Kennedy Fernando; H C Mody; P K Desai; S Meenakshisundaram; P Kaliraj
Journal:  J Ind Microbiol Biotechnol       Date:  2007-08-03       Impact factor: 4.258

4.  Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.

Authors:  Terence Tafatatha; Miriam Taegtmeyer; Bagrey Ngwira; Amos Phiri; Mariot Kondowe; Wilson Piston; Anna Molesworth; Ndoliwe Kayuni; Olivier Koole; Amelia Crampin; John Horton; Neil French
Journal:  PLoS Negl Trop Dis       Date:  2015-06-04

5.  Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.

Authors:  Purushothaman Jambulingam; Swaminathan Subramanian; S J de Vlas; Chellasamy Vinubala; W A Stolk
Journal:  Parasit Vectors       Date:  2016-09-13       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.